Literature DB >> 16206270

HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women.

Paul K S Chan1, Jo L K Cheung, Tak-Hong Cheung, Che-kit Lin, Ann O Y Tam, Denise P C Chan, Daniel X Zhou, Keith W K Lo, So-Fan Yim, Shing-Shun N Siu.   

Abstract

A population-based study was conducted on 256 southern Chinese with cervical intraepithelial neoplasia grade III (CIN III) or invasive cervical cancer (ICC) and on 258 controls to examine the associations between HLA-B alleles, infection with high-risk human papillomaviruses (HPVs) and the development of cervical neoplasia. HLA-B15 was found to be protective for CIN III/ICC overall (p(corrected) = 0.003), and for HPV52-positive CIN III/ICC (p(corrected) = 0.003). A marginal protective effect of B15 was observed for HPV16-positive CIN III/ICC, but no significant associations were revealed for HPV18- or HPV58-positive cases. None of the HLA-B alleles were found to confer an increased risk for cervical neoplasia. HLA-B15 is common among Asian for whom HPV52, a worldwide uncommon HPV type, also exists in a relatively high prevalence. It would also be worthwhile to assess the association between HLA-B15, HPV52 and cervical cancer in other Asian populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16206270     DOI: 10.1002/ijc.21528

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States.

Authors:  Gabriel O Akogbe; Abidemi Ajidahun; Bradley Sirak; Gabriella M Anic; Mary R Papenfuss; William J Fulp; Hui-Yi Lin; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Manuel Quiterio; Danelle Smith; Matthew B Schabath; Jorge Salmeron; Anna R Giuliano
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

2.  Cervical cancer in Indian women reveals contrasting association among common sub-family of HLA class I alleles.

Authors:  Priyanka Gokhale; Jayanti Mania-Pramanik; Archana Sonawani; Susan Idicula-Thomas; Shilpa Kerkar; Hemant Tongaonkar; Hemangi Chaudhari; Himangi Warke; Vinita Salvi
Journal:  Immunogenetics       Date:  2014-09-30       Impact factor: 2.846

3.  Assessment of Human Leukocyte Antigen Differences between Smokers with Reinke's Edema and Those with Laryngeal Cancer.

Authors:  Farzad Izadi; Aslan Ahmadi; Farideh Hosseinzadeh; Marjan Mirsalehi; Yadollah Shakiba; Mohammad Ali Bahar; Maryam Balali
Journal:  Iran J Otorhinolaryngol       Date:  2022-03

4.  Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study.

Authors:  Matthew B Schabath; Luisa L Villa; Hui-Yi Lin; William J Fulp; Gabriel O Akogbe; Martha E Abrahamsen; Mary R Papenfuss; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-19       Impact factor: 4.254

5.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

6.  HLA-A alleles and the risk of cervical squamous cell carcinoma in Japanese women.

Authors:  Satoyo Hosono; Takakazu Kawase; Keitaro Matsuo; Miki Watanabe; Hiroaki Kajiyama; Kaoru Hirose; Takeshi Suzuki; Kumiko Kidokoro; Hidemi Ito; Toru Nakanishi; Yasushi Yatabe; Nobuyuki Hamajima; Fumitaka Kikkawa; Kazuo Tajima; Hideo Tanaka
Journal:  J Epidemiol       Date:  2010-05-22       Impact factor: 3.211

7.  Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment.

Authors:  Yat Ming Lau; Tak Hong Cheung; Winnie Yeo; Frankie Mo; Mei Yung Yu; Kun Min Lee; Wendy C S Ho; Apple C M Yeung; Priscilla T Y Law; Paul K S Chan
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

8.  HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.

Authors:  Rashmirani Senapati; Bhagyalaxmi Nayak; Shantanu Kumar Kar; Bhagirathi Dwibedi
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

Review 9.  The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.

Authors:  Erik Kudela; Alena Liskova; Marek Samec; Lenka Koklesova; Veronika Holubekova; Tomas Rokos; Erik Kozubik; Terezia Pribulova; Kevin Zhai; Dietrich Busselberg; Peter Kubatka; Kamil Biringer
Journal:  EPMA J       Date:  2021-05-18       Impact factor: 8.836

10.  Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide.

Authors:  Paul K S Chan; Wendy C S Ho; Martin C W Chan; Martin C S Wong; Apple C M Yeung; Josette S Y Chor; Mamie Hui
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.